Efectividad y repercusiones de la realización de espirometría en el abordaje terapéutico de los pacientes con EPOC o asmaProyecto “Espiro-RESP”
- Pilar Rodríguez Ledo
- María Teresa Jorge Bravo
- Javier Gamarra Ortiz
- Jesús Hernández Hernández
- María Luisa Pernas Ozores
- Rosa María Carballal González
- Alejandro Veres Racamonde
ISSN: 0214-8986
Year of publication: 2018
Volume: 7
Issue: 4
Type: Article
More publications in: Medicina general
Abstract
Objectives. To assess the impact of spirometry (S) in primary care (PC) on the diagnosis and therapeutic management of patients with respiratory diseases with high prevalence, who require –as indicated by the current clinical practice guidelines (CPG)– of this medical test for correct diagnosis and monitoring: COPD and asthma. Method. Intervention study before-and-after performing S in PC. The eligible population is comprised by patients diagnosed with COPD and asthma, being followed up in PC, without prior relationships to S, which are controlled in consultations by doctors participating in the study. Diagnoses and treatments were compared both before and after the test. Results. 44.6% of patients with COPD and 55.5% of those diagnosed with asthma have S available in clinical practice terms (CPC). Following the completion of S, 27.3% of COPD patients were incorrectly diagnosed and 36.3% (50% of those correctly diagnosed) had their treatment modified, in asthma 12.8 and 15.4% (20.7 %), respectively. The percentage of non-valid S was 7.2% overall, 12% of COPD and 0% in asthma. The average medication was reduced from 5.8 to 4.9 in the COPD drug and from 3.9 to 3.5 in the asthma case. Conclusions. The realization of spirometry is effective and has great clinical relevance in diagnostic and therapeutic aspects, highlighting the need to improve in this very area